« Back to Record
Citation APA

Boussicault, L., Pagès, C., Galvan, L., Piguet, F., Aubourg, P., Cartier, N., Caboche, J., Betuing, S., Alves, S., Lamazière, A., Planques, A., Heck, N., Moumné, L., Despres, G., Bolte, S., & Hu, A. (2016). CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease. Brain, 139(3), 953-970. doi:10.1093/brain/awv384


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/231136

Boussicault, L., Pagès, C., Galvan, L., Piguet, F., Aubourg, P., Cartier, N., Caboche, J., Betuing, S., Alves, S., Lamazière, A., Planques, A., Heck, N., Moumné, L., Despres, G., Bolte, S., & Hu, A. (2016). CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease. Brain, 139(3), 953-970. doi:10.1093/brain/awv384